HPV Pathway Profiling: HPV Related Cervical Dysplasia and Carcinoma Studies

Author(s): Susy M. Scholl, Maud Kamal, Leanne De Koning, Attila Kereszt, Ekaterina S. Jordanova, Sergiu Ungureanu, Els Berns, Xavier Sastre

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 8 , 2013

Become EABM
Become Reviewer


Cervical cancer is the second most common malignancy among women worldwide. While more than 90% of cervical cancers carry one or more high risk HPV types, the exact relationship between HPV oncoproteins and signaling pathways alterations in cervical cancer remains to be clarified. Vaccines and targeted therapies are today considered of great potential for the improvement of patients’ outcome. This review will focus on the interaction of HPV with cervical cancer pathway activations. Next generation high throughput screening technologies for molecular and protein profiling as well as innovative logistics, necessary for the implementation of the personalized care of cervical cancer patients will be discussed.

Keywords: Cervical cancer, HPV, vaccines, omics, targeted therapy, malignancy, oncoproteins, signaling pathways, protein profiling, personalized care

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [1379 - 1394]
Pages: 16
DOI: 10.2174/1381612811319080004
Price: $65

Article Metrics

PDF: 25